News

Washington has long failed to come up with a solution for rising drug prices that addresses the concerns of drugmakers, ...
Shares of Gilead Sciences Inc. GILD slid 2.15% to $112.29 Thursday, on what proved to be an all-around rough trading session ...
A 0.35 mile hike and bike trail expansion along Mount Gilead Road is scheduled to begin in August, according to a July 31 ...
Margaret Atwood’s The Handmaid’s Tale is stitched together from the nastiest bits of actual history. Drawing on Puritan ...
Pheton Holdings Ltd (the “Company,” “we,” “our” or “Pheton”), a healthcare solution provider specializing in treatment ...
Brian Wilson, the man accused of shooting and killing Morrow County Deputy Daniel Sherrer, appeared in court this morning for ...
On July 31, the Trump administration told 17 major drugmakers to align U.S. medication prices with the lowest prices sold in other countries, or the most-favored-nation price.  The White House ...
DAR ES SALLAM: Tanzania has launched a major trade infrastructure project, the East Africa Commercial and Logistics Centre ...
Flying Horse Farms, a medical specialty camp that provides experiences for kids with serious illnesses and their families at no cost, is thrilled to announce its annual Campfire fundraiser on Friday, ...
SINGAPORE (Reuters) -Shares of European drugmakers slipped on Friday after U.S. President Donald Trump sent letters to major ...
Experts are skeptical that Big Pharma companies will cut prices after President Donald Trump demands Most Favored Nation policies within 60 days.
Dealmaking is in style again under President Donald Trump. Potential takeover targets include C3.ai, Viking Therapeutics, and Lyft.